Dardennes R - Search Results

1

Anxiety and depression prevalence rates in age-related macular degeneration.

Augustin A, Sahel JA, Bandello F, Dardennes R, Maurel F, Negrini C, Hieke K, Berdeaux G. Augustin A, et al. Among authors: dardennes r. Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1498-503. doi: 10.1167/iovs.06-0761. Invest Ophthalmol Vis Sci. 2007. PMID: 17389477

2

Comparison of the cost-effectiveness of milnacipran (a SNRI) with TCAs and SSRIs: a modeling approach.

Dardennes R, Berdeaux G, Lafuma A, Fagnani F. Dardennes R, et al. Eur Psychiatry. 1999 Jun;14(3):152-62. doi: 10.1016/s0924-9338(99)80734-2. Eur Psychiatry. 1999. PMID: 10572341 Clinical Trial.

3

[Clinico-economic assessment of milnacipran in the prevention of depressive episodes].

Lafuma A, Dardennes R, Fagnani F, Pribil C, Bisserbe JC, Berdeaux G. Lafuma A, et al. Among authors: dardennes r. Encephale. 1999 Sep-Oct;25(5):401-7. Encephale. 1999. PMID: 10598302 French.

4

Economic assessment of a maintenance treatment strategy in prevention of recurrent depressive disorder.

Dardennes RM, Lafuma A, Fagnani F, Pribil C, Bisserbe JC, Berdeaux G. Dardennes RM, et al. Value Health. 2000 Jan-Feb;3(1):40-7. doi: 10.1046/j.1524-4733.2000.31005.x. Value Health. 2000. PMID: 16464180 Free article.

5

[Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine].

Dardennes R, Lafuma A, Watkins S. Dardennes R, et al. Encephale. 1999 Sep-Oct;25(5):391-400. Encephale. 1999. PMID: 10598301 French.

6

Frequency of hospitalisations and inpatient care costs of manic episodes: in patients with bipolar I disorder in France.

de Zelicourt M, Dardennes R, Verdoux H, Gandhi G, Khoshnood B, Chomette E, Papatheodorou ML, Edgell ET, Even C, Fagnani F. de Zelicourt M, et al. Among authors: dardennes r. Pharmacoeconomics. 2003;21(15):1081-90. doi: 10.2165/00019053-200321150-00002. Pharmacoeconomics. 2003. PMID: 14596627

7

[Bipolar I disorder in France: prevalence of manic episodes and hospitalisation-related costs].

de Zélicourt M, Dardennes R, Verdoux H, Gandhi G, Papatheodorou ML, Edgell ET, Khoshnood B, Chomette E, Even C, Fagnani F. de Zélicourt M, et al. Among authors: dardennes r. Encephale. 2003 May-Jun;29(3 Pt 1):248-53. Encephale. 2003. PMID: 12876549 Review. French.

8

In-patient care costs of patients with bipolar I disorder: a comparison between two European centers.

Gonzalez-Pinto AM, Dardennes R, de Zélicourt M, López P, Oliveros RG, Vieta E, Barbeito S, Echevarria E, Fagnani F. Gonzalez-Pinto AM, et al. Among authors: dardennes r. J Affect Disord. 2010 Feb;121(1-2):152-5. doi: 10.1016/j.jad.2009.05.010. Epub 2009 May 31. J Affect Disord. 2010. PMID: 19482360

9

Critical approach to antidepressant trials. Blindness protection is necessary, feasible and measurable.

Even C, Siobud-Dorocant E, Dardennes RM. Even C, et al. Among authors: dardennes rm. Br J Psychiatry. 2000 Jul;177:47-51. doi: 10.1192/bjp.177.1.47. Br J Psychiatry. 2000. PMID: 10945088 Review.

10

Are washout periods useful in antidepressant trials?

Even C, Friedman S, Dardennes R. Even C, et al. Among authors: dardennes r. Eur Psychiatry. 2000 Sep;15(6):391. doi: 10.1016/s0924-9338(00)00508-3. Eur Psychiatry. 2000. PMID: 11004735 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters